These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38546978)

  • 1. Role of KCNK3 Dysfunction in Dasatinib-associated Pulmonary Arterial Hypertension and Endothelial Cell Dysfunction.
    Ribeuz HL; Willer AS; Chevalier B; Sancho M; Masson B; Eyries M; Jung V; Guerrera IC; Dutheil M; Jekmek KE; Laubry L; Carpentier G; Perez-Vizcaino F; Tu L; Guignabert C; Chaumais MC; Péchoux C; Humbert M; Hinzpeter A; Mercier O; Capuano V; Montani D; Antigny F
    Am J Respir Cell Mol Biol; 2024 Jul; 71(1):95-109. PubMed ID: 38546978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic Analysis of KCNK3 Loss of Expression Identified Dysregulated Pathways in Pulmonary Vascular Cells.
    Le Ribeuz H; Dumont F; Ruellou G; Lambert M; Balliau T; Quatredeniers M; Girerd B; Cohen-Kaminsky S; Mercier O; Yen-Nicolaÿ S; Humbert M; Montani D; Capuano V; Antigny F
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33036472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potassium Channel Subfamily K Member 3 (KCNK3) Contributes to the Development of Pulmonary Arterial Hypertension.
    Antigny F; Hautefort A; Meloche J; Belacel-Ouari M; Manoury B; Rucker-Martin C; Péchoux C; Potus F; Nadeau V; Tremblay E; Ruffenach G; Bourgeois A; Dorfmüller P; Breuils-Bonnet S; Fadel E; Ranchoux B; Jourdon P; Girerd B; Montani D; Provencher S; Bonnet S; Simonneau G; Humbert M; Perros F
    Circulation; 2016 Apr; 133(14):1371-85. PubMed ID: 26912814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of Heterozygous
    Bohnen MS; Roman-Campos D; Terrenoire C; Jnani J; Sampson KJ; Chung WK; Kass RS
    J Am Heart Assoc; 2017 Sep; 6(9):. PubMed ID: 28889099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kcnk3 dysfunction exaggerates the development of pulmonary hypertension induced by left ventricular pressure overload.
    Lambert M; Mendes-Ferreira P; Ghigna MR; LeRibeuz H; Adão R; Boet A; Capuano V; Rucker-Martin C; Brás-Silva C; Quarck R; Domergue V; Vachiéry JL; Humbert M; Perros F; Montani D; Antigny F
    Cardiovasc Res; 2021 Nov; 117(12):2474-2488. PubMed ID: 33483721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crosstalk between BMP signaling and KCNK3 in phenotypic switching of pulmonary vascular smooth muscle cells.
    Yeo Y; Jeong H; Kim M; Choi Y; Kim KL; Suh W
    BMB Rep; 2022 Nov; 55(11):565-570. PubMed ID: 36016502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of
    Lambert M; Capuano V; Boet A; Tesson L; Bertero T; Nakhleh MK; Remy S; Anegon I; Pechoux C; Hautefort A; Rucker-Martin C; Manoury B; Domergue V; Mercier O; Girerd B; Montani D; Perros F; Humbert M; Antigny F
    Circ Res; 2019 Sep; 125(7):678-695. PubMed ID: 31347976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo miR-138-5p inhibition alleviates monocrotaline-induced pulmonary hypertension and normalizes pulmonary KCNK3 and SLC45A3 expression.
    Le Ribeuz H; Courboulin A; Ghigna MR; Lambert M; Hautefort A; Humbert M; Montani D; Cohen-Kaminsky S; Perros F; Antigny F
    Respir Res; 2020 Jul; 21(1):186. PubMed ID: 32678044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of KCNK3 is a hallmark of RV hypertrophy/dysfunction associated with pulmonary hypertension.
    Lambert M; Boet A; Rucker-Martin C; Mendes-Ferreira P; Capuano V; Hatem S; Adão R; Brás-Silva C; Hautefort A; Michel JB; Dorfmuller P; Fadel E; Kotsimbos T; Price L; Jourdon P; Montani D; Humbert M; Perros F; Antigny F
    Cardiovasc Res; 2018 May; 114(6):880-893. PubMed ID: 29360952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA‑138 promotes proliferation and suppresses mitochondrial depolarization in human pulmonary artery smooth muscle cells through targeting TASK‑1.
    Liu JJ; Zhang H; Xing F; Tang B; Wu SL; Xuan L; Kang PF; Xu Q; Wang HJ; Zhang NR; Wang XJ
    Mol Med Rep; 2018 Feb; 17(2):3021-3027. PubMed ID: 29257242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KCNK3 Mutation Causes Altered Immune Function in Pulmonary Arterial Hypertension Patients and Mouse Models.
    West JD; Austin ED; Rizzi EM; Yan L; Tanjore H; Crabtree AL; Moore CS; Muthian G; Carrier EJ; Jacobson DA; Hamid R; Kendall PL; Majka S; Rathinasabapathy A
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34065088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of transient receptor potential canonical channels in human and experimental pulmonary arterial hypertension.
    Masson B; Saint-Martin Willer A; Dutheil M; Penalva L; Le Ribeuz H; El Jekmek K; Ruchon Y; Cohen-Kaminsky S; Sabourin J; Humbert M; Mercier O; Montani D; Capuano V; Antigny F
    Am J Physiol Lung Cell Mol Physiol; 2023 Aug; 325(2):L246-L261. PubMed ID: 37366608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization and regulation of wild-type and mutant TASK-1 two pore domain potassium channels indicated in pulmonary arterial hypertension.
    Cunningham KP; Holden RG; Escribano-Subias PM; Cogolludo A; Veale EL; Mathie A
    J Physiol; 2019 Feb; 597(4):1087-1101. PubMed ID: 30365877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of lncRNA Gas5 promotes hypoxia-induced pulmonary arterial smooth muscle cell proliferation by regulating KCNK3 expression.
    Hao X; Li H; Zhang P; Yu X; Jiang J; Chen S
    Eur J Pharmacol; 2020 Dec; 889():173618. PubMed ID: 33010302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physiological and pathophysiological roles of the KCNK3 potassium channel in the pulmonary circulation and the heart.
    Saint-Martin Willer A; Santos-Gomes J; Adão R; Brás-Silva C; Eyries M; Pérez-Vizcaino F; Capuano V; Montani D; Antigny F
    J Physiol; 2023 Sep; 601(17):3717-3737. PubMed ID: 37477289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uncovered Contribution of Kv7 Channels to Pulmonary Vascular Tone in Pulmonary Arterial Hypertension.
    Mondéjar-Parreño G; Barreira B; Callejo M; Morales-Cano D; Barrese V; Esquivel-Ruiz S; Olivencia MA; Macías M; Moreno L; Greenwood IA; Perez-Vizcaino F; Cogolludo A
    Hypertension; 2020 Oct; 76(4):1134-1146. PubMed ID: 32829658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CircST6GAL1 knockdown alleviates pulmonary arterial hypertension by regulating miR-509-5p/multiple C2 and transmembrane domain containing 2 axis.
    Zhang X; Qin H; Ma Q; Zhang J; Tian H; Meng Y
    Clin Respir J; 2024 May; 18(5):e13771. PubMed ID: 38747117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of RELM-β prevents hypoxia-induced overproliferation of human pulmonary artery smooth muscle cells by reversing PLC-mediated KCNK3 decline.
    Han L; Song N; Hu X; Zhu A; Wei X; Liu J; Yuan S; Mao W; Chen X
    Life Sci; 2020 Apr; 246():117419. PubMed ID: 32045592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cathepsin S promotes the development of pulmonary arterial hypertension.
    Chang CJ; Hsu HC; Ho WJ; Chang GJ; Pang JS; Chen WJ; Huang CC; Lai YJ
    Am J Physiol Lung Cell Mol Physiol; 2019 Jul; 317(1):L1-L13. PubMed ID: 31017016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA-SMILR modulates RhoA/ROCK signaling by targeting miR-141 to regulate vascular remodeling in pulmonary arterial hypertension.
    Lei S; Peng F; Li ML; Duan WB; Peng CQ; Wu SJ
    Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H377-H391. PubMed ID: 32559140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.